What question did this study set out to answer?

This review examines the safety concerns and risk stratification of iodinated contrast media in oncologic imaging.

May 17, 2026DiagnosticsOpen Access

Iodinated Contrast Media in Oncologic CT: A Narrative Review of Safety, Risk Stratification, and Practical Considerations

View Full Paper

Ask AI

Bookmark

This review examines the safety concerns and risk stratification of iodinated contrast media in oncologic imaging.
Conducted a narrative review of literature on iodinated contrast use in oncology;
Included studies focusing on renal risk, acute kidney injury, hypersensitivity reactions, and thyroid dysfunction.
Evaluated drug interactions, isotope studies, and laboratory variations.
Kidney injury from contrast-enhanced imaging is often multifactorial, indicating a broader risk of acute kidney injury.
Severe hypersensitivity reactions to modern nonionic iodinated contrast media are rare, although immune therapies may increase risk.
Transient thyroid-related effects were noted, especially in patients with thyroid conditions affecting radioiodine therapy.

No takes yet. Share an insight, caveat, or question.

Narrative review explores safety risks and considerations for iodinated contrast in cancer imaging, indicating tailored risk assessment is essential.

Vasii et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Narrative review explores safety risks and considerations for iodinated contrast in cancer imaging, indicating tailored risk assessment is essential.